Mitsubishi UFJ Trust & Banking Corp boosted its holdings in Colgate-Palmolive (NYSE:CL – Free Report) by 0.7% during the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 983,122 shares of the company’s stock after buying an additional 6,594 shares during the period. Mitsubishi UFJ Trust & Banking Corp owned approximately 0.12% of Colgate-Palmolive worth $88,125,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Te Ahumairangi Investment Management Ltd lifted its position in Colgate-Palmolive by 4.1% during the 1st quarter. Te Ahumairangi Investment Management Ltd now owns 45,117 shares of the company’s stock worth $4,063,000 after acquiring an additional 1,760 shares in the last quarter. First Foundation Advisors boosted its stake in shares of Colgate-Palmolive by 37.9% in the first quarter. First Foundation Advisors now owns 1,626 shares of the company’s stock valued at $146,000 after purchasing an additional 447 shares during the period. Mizuho Markets Americas LLC grew its holdings in Colgate-Palmolive by 104.3% during the 1st quarter. Mizuho Markets Americas LLC now owns 126,867 shares of the company’s stock valued at $11,424,000 after purchasing an additional 64,773 shares in the last quarter. M&G Plc purchased a new stake in Colgate-Palmolive during the 1st quarter worth $3,812,000. Finally, Banco Santander S.A. boosted its stake in shares of Colgate-Palmolive by 77.5% during the 1st quarter. Banco Santander S.A. now owns 19,319 shares of the company’s stock valued at $1,740,000 after buying an additional 8,436 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several analysts recently issued reports on the stock. Morgan Stanley upped their price target on shares of Colgate-Palmolive from $101.00 to $103.00 and gave the company an “overweight” rating in a report on Tuesday, May 28th. Evercore ISI boosted their target price on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the company an “outperform” rating in a research note on Thursday. Barclays raised their price target on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the company an “equal weight” rating in a research note on Friday. Deutsche Bank Aktiengesellschaft increased their price objective on Colgate-Palmolive from $98.00 to $104.00 and gave the stock a “buy” rating in a report on Wednesday. Finally, Stifel Nicolaus lifted their target price on Colgate-Palmolive from $94.00 to $95.00 and gave the company a “buy” rating in a research note on Monday, April 29th. Three research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $96.94.
Insider Activity at Colgate-Palmolive
In other Colgate-Palmolive news, insider Sally Massey sold 12,226 shares of the firm’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $94.06, for a total value of $1,149,977.56. Following the sale, the insider now owns 13,924 shares of the company’s stock, valued at approximately $1,309,691.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, insider Sally Massey sold 12,226 shares of the stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $94.06, for a total value of $1,149,977.56. Following the completion of the sale, the insider now owns 13,924 shares in the company, valued at $1,309,691.44. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider John W. Kooyman sold 3,497 shares of the business’s stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total value of $326,864.59. Following the transaction, the insider now owns 3,181 shares in the company, valued at $297,328.07. The disclosure for this sale can be found here. 0.34% of the stock is currently owned by company insiders.
Colgate-Palmolive Stock Up 0.1 %
NYSE CL traded up $0.07 during trading on Friday, reaching $98.08. The company’s stock had a trading volume of 4,229,242 shares, compared to its average volume of 3,864,903. The stock has a market capitalization of $80.47 billion, a PE ratio of 31.04, a PEG ratio of 3.54 and a beta of 0.39. The business has a 50-day moving average price of $95.53 and a 200-day moving average price of $89.53. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 13.21. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $99.63.
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its quarterly earnings data on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.82 by $0.04. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The firm had revenue of $5.07 billion during the quarter, compared to analysts’ expectations of $4.96 billion. During the same period in the prior year, the company posted $0.73 earnings per share. Colgate-Palmolive’s revenue for the quarter was up 6.2% on a year-over-year basis. On average, research analysts forecast that Colgate-Palmolive will post 3.54 earnings per share for the current fiscal year.
Colgate-Palmolive Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be given a dividend of $0.50 per share. The ex-dividend date is Friday, July 19th. This represents a $2.00 dividend on an annualized basis and a yield of 2.04%. Colgate-Palmolive’s payout ratio is currently 63.29%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- What Are Dividend Champions? How to Invest in the Champions
- Why This AI Stock is Rising Despite Tech Sell-Off
- What is the S&P 500 and How It is Distinct from Other Indexes
- MarketBeat Week in Review – 7/15 – 7/19
- High Flyers: 3 Natural Gas Stocks for March 2022
- Investors Are Moving into Bonds and Small Cap Stocks: Here’s Why
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.